Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 12 | 2020 | 312 | 3.040 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2020 | 1221 | 1.760 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2020 | 1389 | 1.300 |
Why?
|
| Brain | 10 | 2020 | 930 | 1.120 |
Why?
|
| Artificial Intelligence | 3 | 2013 | 49 | 0.940 |
Why?
|
| Aged | 35 | 2024 | 9572 | 0.880 |
Why?
|
| Risk Assessment | 3 | 2018 | 1327 | 0.850 |
Why?
|
| Diet Therapy | 2 | 2020 | 13 | 0.760 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 47 | 0.690 |
Why?
|
| Databases, Factual | 2 | 2018 | 333 | 0.680 |
Why?
|
| Humans | 49 | 2024 | 29449 | 0.640 |
Why?
|
| Female | 39 | 2024 | 18341 | 0.640 |
Why?
|
| Exercise Therapy | 2 | 2020 | 237 | 0.640 |
Why?
|
| Oxygen | 2 | 2009 | 139 | 0.610 |
Why?
|
| Postmenopause | 5 | 2024 | 398 | 0.610 |
Why?
|
| Metabolomics | 3 | 2017 | 45 | 0.610 |
Why?
|
| Nerve Net | 2 | 2016 | 115 | 0.610 |
Why?
|
| Dementia | 4 | 2024 | 237 | 0.600 |
Why?
|
| Body Weight | 2 | 2020 | 290 | 0.540 |
Why?
|
| Aged, 80 and over | 19 | 2021 | 3758 | 0.540 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 119 | 0.540 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 141 | 0.520 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 1055 | 0.490 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 64 | 0.470 |
Why?
|
| Cerebrovascular Circulation | 3 | 2017 | 95 | 0.470 |
Why?
|
| Brain Mapping | 5 | 2011 | 182 | 0.460 |
Why?
|
| Women's Health | 6 | 2024 | 226 | 0.450 |
Why?
|
| Algorithms | 7 | 2020 | 468 | 0.450 |
Why?
|
| Male | 24 | 2024 | 17969 | 0.420 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 242 | 0.420 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 2121 | 0.400 |
Why?
|
| Middle Aged | 19 | 2024 | 10920 | 0.390 |
Why?
|
| Air Pollution | 2 | 2024 | 17 | 0.370 |
Why?
|
| Particulate Matter | 3 | 2024 | 30 | 0.370 |
Why?
|
| Cognition Disorders | 4 | 2019 | 391 | 0.360 |
Why?
|
| Estrogens | 1 | 2011 | 163 | 0.350 |
Why?
|
| Models, Theoretical | 2 | 2016 | 131 | 0.350 |
Why?
|
| Aging | 6 | 2024 | 888 | 0.340 |
Why?
|
| Risk Factors | 10 | 2024 | 3596 | 0.330 |
Why?
|
| Behavior Therapy | 2 | 2020 | 92 | 0.330 |
Why?
|
| Hemodynamics | 1 | 2009 | 148 | 0.320 |
Why?
|
| Cognition | 6 | 2019 | 528 | 0.310 |
Why?
|
| Hormone Replacement Therapy | 2 | 2019 | 86 | 0.300 |
Why?
|
| Exercise | 4 | 2021 | 608 | 0.290 |
Why?
|
| Life Style | 2 | 2020 | 369 | 0.290 |
Why?
|
| Models, Biological | 1 | 2009 | 373 | 0.290 |
Why?
|
| Aldosterone | 2 | 2017 | 28 | 0.290 |
Why?
|
| Longitudinal Studies | 6 | 2020 | 725 | 0.280 |
Why?
|
| Incidence | 6 | 2024 | 1126 | 0.280 |
Why?
|
| Memory Disorders | 2 | 2018 | 61 | 0.280 |
Why?
|
| Software | 1 | 2006 | 110 | 0.270 |
Why?
|
| Renin | 2 | 2017 | 113 | 0.270 |
Why?
|
| Genome-Wide Association Study | 3 | 2024 | 546 | 0.270 |
Why?
|
| Geriatric Assessment | 2 | 2018 | 363 | 0.270 |
Why?
|
| Environmental Exposure | 3 | 2024 | 87 | 0.260 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2016 | 125 | 0.250 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 21 | 0.240 |
Why?
|
| Wrist | 2 | 2021 | 40 | 0.240 |
Why?
|
| Tomography | 1 | 2004 | 4 | 0.240 |
Why?
|
| Magnetics | 1 | 2004 | 5 | 0.240 |
Why?
|
| Weight Loss | 2 | 2017 | 415 | 0.240 |
Why?
|
| Air Pollutants | 1 | 2024 | 20 | 0.240 |
Why?
|
| Antidepressive Agents | 1 | 2024 | 71 | 0.230 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 100 | 0.230 |
Why?
|
| Insulin Resistance | 2 | 2017 | 450 | 0.230 |
Why?
|
| DNA Methylation | 1 | 2024 | 131 | 0.230 |
Why?
|
| Inflammation | 4 | 2024 | 510 | 0.220 |
Why?
|
| Computer Simulation | 4 | 2009 | 211 | 0.220 |
Why?
|
| African Americans | 4 | 2017 | 1375 | 0.220 |
Why?
|
| Adult | 12 | 2021 | 8511 | 0.220 |
Why?
|
| Baltimore | 3 | 2018 | 49 | 0.210 |
Why?
|
| Apolipoprotein E4 | 2 | 2020 | 58 | 0.210 |
Why?
|
| Phenotype | 1 | 2024 | 633 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 840 | 0.200 |
Why?
|
| Blood Pressure | 2 | 2024 | 812 | 0.200 |
Why?
|
| Young Adult | 8 | 2021 | 2423 | 0.200 |
Why?
|
| Depression | 1 | 2024 | 386 | 0.190 |
Why?
|
| Logistic Models | 2 | 2013 | 729 | 0.190 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 376 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 72 | 0.180 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 727 | 0.180 |
Why?
|
| Brain Ischemia | 2 | 2012 | 136 | 0.180 |
Why?
|
| Health Care Costs | 1 | 2020 | 108 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 376 | 0.170 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 235 | 0.170 |
Why?
|
| Electronic Health Records | 1 | 2020 | 121 | 0.170 |
Why?
|
| Medicare | 1 | 2020 | 189 | 0.170 |
Why?
|
| Cohort Studies | 6 | 2020 | 1701 | 0.170 |
Why?
|
| Coronary Disease | 2 | 2017 | 202 | 0.170 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 77 | 0.170 |
Why?
|
| Disease Progression | 2 | 2018 | 574 | 0.160 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 136 | 0.160 |
Why?
|
| Auditory Cortex | 2 | 2009 | 22 | 0.160 |
Why?
|
| Visual Cortex | 2 | 2009 | 33 | 0.160 |
Why?
|
| Diabetes Complications | 1 | 2019 | 171 | 0.160 |
Why?
|
| Mass Screening | 1 | 2020 | 226 | 0.160 |
Why?
|
| Blood | 1 | 2018 | 8 | 0.160 |
Why?
|
| Gyrus Cinguli | 2 | 2016 | 22 | 0.160 |
Why?
|
| Models, Psychological | 1 | 2018 | 22 | 0.160 |
Why?
|
| Metabolome | 1 | 2018 | 31 | 0.160 |
Why?
|
| Atherosclerosis | 1 | 2024 | 728 | 0.150 |
Why?
|
| Neoplasms | 1 | 2024 | 621 | 0.150 |
Why?
|
| Lipids | 1 | 2019 | 215 | 0.150 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 1380 | 0.150 |
Why?
|
| Auditory Perception | 2 | 2009 | 80 | 0.150 |
Why?
|
| Cholesterol | 1 | 2019 | 239 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 20 | 0.150 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 17 | 0.150 |
Why?
|
| Visual Perception | 2 | 2009 | 112 | 0.150 |
Why?
|
| alpha-Macroglobulins | 1 | 2016 | 4 | 0.150 |
Why?
|
| Phospholipids | 1 | 2017 | 27 | 0.150 |
Why?
|
| Health Education | 1 | 2018 | 131 | 0.140 |
Why?
|
| Muscle Proteins | 1 | 2016 | 57 | 0.140 |
Why?
|
| Demography | 1 | 2016 | 104 | 0.140 |
Why?
|
| Anthropometry | 1 | 2016 | 82 | 0.140 |
Why?
|
| Waist Circumference | 1 | 2016 | 90 | 0.140 |
Why?
|
| Glucose | 1 | 2017 | 165 | 0.140 |
Why?
|
| Leptin | 1 | 2016 | 66 | 0.140 |
Why?
|
| Radiography | 2 | 2016 | 355 | 0.140 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 167 | 0.140 |
Why?
|
| Adiponectin | 1 | 2016 | 103 | 0.140 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 53 | 0.130 |
Why?
|
| Triglycerides | 1 | 2016 | 218 | 0.130 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 69 | 0.130 |
Why?
|
| Stroke | 2 | 2017 | 552 | 0.130 |
Why?
|
| Diet | 1 | 2017 | 356 | 0.130 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 8 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2016 | 85 | 0.120 |
Why?
|
| Decision Trees | 1 | 2014 | 23 | 0.120 |
Why?
|
| Prognosis | 1 | 2018 | 1369 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2016 | 182 | 0.120 |
Why?
|
| Apolipoproteins E | 3 | 2019 | 97 | 0.120 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 182 | 0.120 |
Why?
|
| ROC Curve | 1 | 2014 | 149 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2016 | 469 | 0.120 |
Why?
|
| United States | 5 | 2020 | 3685 | 0.120 |
Why?
|
| Time Factors | 1 | 2018 | 2013 | 0.110 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 60 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2020 | 2041 | 0.110 |
Why?
|
| Retinal Vessels | 1 | 2012 | 18 | 0.100 |
Why?
|
| Retinal Diseases | 1 | 2012 | 18 | 0.100 |
Why?
|
| Linear Models | 1 | 2012 | 427 | 0.100 |
Why?
|
| Horses | 1 | 2011 | 13 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2011 | 70 | 0.100 |
Why?
|
| Attention | 2 | 2009 | 84 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2011 | 40 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 1077 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2011 | 113 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2011 | 115 | 0.090 |
Why?
|
| Energy Metabolism | 2 | 2021 | 139 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 638 | 0.080 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 7 | 0.080 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 34 | 0.080 |
Why?
|
| Organ Size | 3 | 2016 | 196 | 0.080 |
Why?
|
| Normal Distribution | 1 | 2008 | 12 | 0.080 |
Why?
|
| Activities of Daily Living | 2 | 2021 | 241 | 0.080 |
Why?
|
| Neural Inhibition | 1 | 2008 | 27 | 0.080 |
Why?
|
| Bayes Theorem | 1 | 2008 | 69 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 31 | 0.070 |
Why?
|
| tau Proteins | 2 | 2017 | 38 | 0.070 |
Why?
|
| Risk | 2 | 2019 | 292 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 130 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2006 | 107 | 0.070 |
Why?
|
| Adolescent | 4 | 2020 | 3278 | 0.060 |
Why?
|
| Electromagnetic Fields | 1 | 2004 | 26 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2024 | 95 | 0.060 |
Why?
|
| Artifacts | 1 | 2004 | 38 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2017 | 873 | 0.060 |
Why?
|
| Mortality | 1 | 2024 | 114 | 0.060 |
Why?
|
| Medicare Part A | 1 | 2020 | 5 | 0.050 |
Why?
|
| Medicare Part B | 1 | 2020 | 5 | 0.050 |
Why?
|
| Wrist Joint | 1 | 2021 | 53 | 0.050 |
Why?
|
| Medicare Part D | 1 | 2020 | 8 | 0.050 |
Why?
|
| Eligibility Determination | 1 | 2020 | 14 | 0.050 |
Why?
|
| Health Services | 1 | 2020 | 35 | 0.050 |
Why?
|
| Age of Onset | 1 | 2020 | 95 | 0.050 |
Why?
|
| Counseling | 1 | 2020 | 86 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2020 | 61 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2020 | 215 | 0.040 |
Why?
|
| Apolipoprotein C-I | 1 | 2019 | 4 | 0.040 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2019 | 14 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2019 | 13 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2012 | 380 | 0.040 |
Why?
|
| Animals | 1 | 2011 | 7328 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 36 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 180 | 0.040 |
Why?
|
| Forecasting | 1 | 2019 | 133 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 21 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 796 | 0.040 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2017 | 2 | 0.040 |
Why?
|
| Problem Solving | 1 | 2018 | 28 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2017 | 7 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 422 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2017 | 7 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2017 | 25 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2017 | 56 | 0.040 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 21 | 0.040 |
Why?
|
| Acoustic Stimulation | 2 | 2009 | 125 | 0.040 |
Why?
|
| Hypertension | 1 | 2024 | 916 | 0.040 |
Why?
|
| Thiazoles | 1 | 2017 | 32 | 0.040 |
Why?
|
| Sleep | 1 | 2018 | 88 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 440 | 0.040 |
Why?
|
| Calcineurin | 1 | 2016 | 3 | 0.040 |
Why?
|
| Sample Size | 1 | 2017 | 37 | 0.040 |
Why?
|
| Amino Acids | 1 | 2017 | 41 | 0.040 |
Why?
|
| Prevalence | 1 | 2019 | 910 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 92 | 0.040 |
Why?
|
| Fasting | 1 | 2017 | 93 | 0.040 |
Why?
|
| Cause of Death | 1 | 2017 | 222 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2017 | 188 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2018 | 182 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2016 | 64 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 226 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 143 | 0.030 |
Why?
|
| Knee Prosthesis | 1 | 2016 | 14 | 0.030 |
Why?
|
| Proteomics | 1 | 2016 | 92 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 287 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 253 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 371 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 711 | 0.030 |
Why?
|
| Osteoarthritis, Knee | 1 | 2016 | 81 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 204 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 633 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 1080 | 0.030 |
Why?
|
| Knee Joint | 1 | 2016 | 129 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 483 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 423 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 423 | 0.030 |
Why?
|
| Neurons | 1 | 2016 | 394 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 469 | 0.030 |
Why?
|
| Quality of Life | 1 | 2018 | 828 | 0.030 |
Why?
|
| Reference Values | 1 | 2011 | 224 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 455 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2009 | 155 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3123 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2008 | 16 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2008 | 59 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2008 | 97 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2008 | 81 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2006 | 52 | 0.020 |
Why?
|
| Movement | 1 | 2006 | 41 | 0.020 |
Why?
|
| Fingers | 1 | 2006 | 57 | 0.020 |
Why?
|